Alterity Therapeutics Limited
ATH
Kedudukan dalam Saham
#26014
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Harga Saham
$0.1904269
Modal Pasaran
$41.61M
Perubahan (1 hari)
-3.57%
Perubahan (1 tahun)
-45.59%
Negara
AU
Perdagangan Alterity Therapeutics Limited (ATH)
Kategori
Healthcare
Sejarah pecahan saham untuk Alterity Therapeutics Limited (ATH)
Saham Alterity Therapeutics Limited (simbol: ATH) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham ATH yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham ATH.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham ATH yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham ATH.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
